Author:
Nishimoto Tomoyuki,Amano Yuichiro,Tozawa Ryuichi,Ishikawa Eiichiro,Imura Yoshimi,Yukimasa Hidefumi,Sugiyama Yasuo
Reference30 articles.
1. RPR 107393, a potent squalene synthase inhibitor and orally effective cholesterol-lowering agent:comparison with inhibitors of HMG-CoA reductase;AMIN;J. Pharmacol. Exp. Ther.,1997
2. Cholesterol and mortality. 30 years of follow-up from the Framingham Study;ANDERSON;J. Am. Med. Assoc.,1987
3. Plasma triglyceride and coronary heart disease;AUSTIN;Arterioscler. Thromb. Vasc. Biol.,1991
4. Efficacy and safety of a new HMG-CoA reductase inhibitor, atorvastatin, in patients with hypertriglyceridemia;BAKKER-ARKEMA;J. Am. Med. Assoc.,1996
5. Squalestatin 1, a potent inhibitor of squalene synthase, which lowers serum cholesterol in vivo;BAXTER;J. Biol. Chem.,1992
Cited by
74 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献